Amin Sharifan, PharmD
Wissenschaftlicher Mitarbeiter - Department für Evidenzbasierte Medizin und Evaluation
-
amin.sharifan@donau-uni.ac.at
-
+43 2732 893-5399
-
Zum Kontaktformular
- Universität für Weiterbildung Krems
- Department für Evidenzbasierte Medizin und Evaluation
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Österreich
Funktionen
Amin Sharifan ist als wissenschaftlicher Mitarbeiter und PhD-Student für Projekte im Bereich der evidenzbasierten Medizin zuständig.
Projekte (Auszug Forschungsdatenbank)
Laufende Projekte
Projektzeitraum: 01.08.2025–31.01.2026
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Projektzeitraum: 01.08.2025–31.01.2026
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Projektzeitraum: 01.07.2025–30.06.2026
Projektverantwortung (Universität für Weiterbildung Krems): Andreea Dobrescu
Fördergeber: andere internationale Organisationen
Projektzeitraum: 01.04.2025–31.03.2028
Projektverantwortung (Universität für Weiterbildung Krems): Amin Sharifan
Fördergeber: Bundesländer (inkl. deren Stiftungen und Einrichtungen)
Evidence Review on Pharmacologic Treatment of Chronic Insomnia
Projektzeitraum: 01.03.2025–28.02.2027
Projektverantwortung (Universität für Weiterbildung Krems): Andreea Dobrescu
Fördergeber: Sonstige
Projektzeitraum: 01.11.2024–30.04.2025
Projektverantwortung (Universität für Weiterbildung Krems): Andreea Dobrescu
Update of a Rapid Review on Outpatient Treat-ment of Confirmed COVID-19 (Version 3)
Projektzeitraum: 01.09.2024–30.09.2025
Projektverantwortung (Universität für Weiterbildung Krems): Isolde Sommer
Fördergeber: Sonstige
Interpretation of Non-significant Differences
Projektzeitraum: 01.12.2022–31.12.2024
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Abgeschlossene Projekte
Projektzeitraum: 15.07.2025–31.01.2026
Projektverantwortung (Universität für Weiterbildung Krems): Andreea Dobrescu
Fördergeber: andere internationale Organisationen
Projektzeitraum: 01.12.2024–30.09.2025
Projektverantwortung (Universität für Weiterbildung Krems): Gerald Gartlehner
Publikationen (Auszug Forschungsdatenbank)
Abdulazeem, H.; Borges do Nascimento, I.J.; Weerasekara, I.; Sharifan, A.; Grandi Bianco, V.; Cunningham, C.; Kularathne, I.; Deeken, G.; de Barros, J.; Sathian, B.; Østengaard, L.; Lamontagne-Godwin, F.; van Hoof, J.; Lazeri, L.; Redlich, C.; Marston, H.R.; Alistair Dos Santos, R.; Azzopardi-Muscat, N.; Yon, Y.; Novillo-Ortiz, D. (2025). Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report. JMIR Ment Health, 12:e64445: 10.2196/64445
Borges do Nascimento, I.J.; Abdulazeem, H.M.; Weerasekara, I.; Sharifan, A.; Grandi Bianco, V.; Kularathne, I.; Cunningham, C.; Sathian, B.; Deeken, G.; Østengaard, L.; Frederique-Djurdjevic, R.; van Hoof, J.; Lazeri, L.; Redlich, C.; Marston, H.R.; Sernizon uimarães, N.; de Barros, J.; dos Santos, R.A.; Azzopardi-Muscat, N.; Yon, Y.; (2025). An Overview of Reviews on Telemedicine and Telehealth in Dementia Care: Mixed Methods Synthesis An Overview of Reviews on Telemedicine and Telehealth in Dementia Care: Mixed Methods Synthesis. JMIR Mental Health, 12: e75266
Dobrescu, A.; Nussbaumer-Streit, B.; Wagner, G.; Sharifan, A.; Gadinger, A.; Klerings, I.; Nowak, C.; Gartlehner, G. (2025). Assessing the Impact of Unpublished Data on Network Meta-Analysis Outcomes in Outpatient Adults with Acute Migraine: A Study within a Review. Journal of Clinical Epidemiology, 112014: https://doi.org/10.1016/j.jclinepi.2025.112014
Dobrescu, A.I.; Sharifan, A.; Sommer, I.; Neubauer-Bruckner, C.I.A.; Gadinger, A.; Klerings, I.; Nowak, C.; Gartlehner, G. (2025). Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Annals of Internal Medicine, Online ahead of prin: 10.7326/ANNALS-25-04028
Feigin, V. L. ; Vos, T.; Nair, B. S.; Hay, S. I.; Abate, Y. H.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, 10: e203-27
GBD 2021 Europe Life Expectancy Collaborators; Steel, N., Sharifan, A. (2025). Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health, 10: e172–88
GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators (2025). Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage. The Global Burden of Disease Study 2021. JAMA Neurology, 10.1001/jamaneurol.2025.1522: E1-E23
GBD 2021 Headache Collaborators; Sharifan, A. (2025). Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021. Cell Reports Medicine, 6, 10: 102348
GBD 2021 Suicide Collaborators; Davis Weaver, N.; Sharifan, A.; (2025). Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health, 10: e189-e202
GBD 2023 Cancer Collaborators; Sharifan, A. (2025). The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 406, 10512: P1565-1586
Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators; Sharifan, A. (2025). Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. The Journal of the American College of Cardiology (JACC), Article in press: https://doi.org/10.1016/j.jacc.2025.08.015
Gray, A.P.; et. al.; Sharifan, A. (2025). Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis. The Lancet Global Health, 13, 12: E2013-2026
Haeuser, E.; Byrne, S.; Nguyen, J.; Raggi, C.; McLaughlin, S.A.; Bisignano, C.; et al. Sharifan, A: (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10500: 235-260
Hay, S.I.; et. al.; Sharifan, A. (2025). Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 20. The Lancet, 406, 10513: P1873-1922
Hus?y, A. K.; et. al.; Sharifan, A. (2025). Global, regional, and national burden of headache disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Neurology, Volume 24, Issue 12: p1005-1015
Kerr, J. A.; Patton, G. C.; Cini, K. I.; Abate, Y. H.; Abbas, N.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 785-812
Li, S.; Zhang, L.; Wang, Y.; Xie, R.; Chen, W.; Soo Lee, M.; Amer, Y.S.; Sharifan, A.; Hussein, H.; Li, H. (2025). Development and validation a methodology model for traditional Chinese medicine good practice recommendation: an exploratory sequential mixed methods study. Frontiers in Pharmacology, 16:1501634: 10.3389/fphar.2025.1501634
M. Ng,; E. Gakidou,; J. Lo,; Y. H. Abate,; C. Abbafati,; N. Abbas,; et al. (2025). Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 813-38
Mark, P.B.; et. al.; Sharifan, A. (2025). Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10518: p2461-2482
Mestrovic, T.; et. al.; Sharifan, A. (2025). The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050. The Lancet Public Health, 10, 11: E955-970
Tags